Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Remarks:
Skin Irritation Test
Adequacy of study:
key study
Study period:
2022-02-10 until 2022-03-18
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Title:
Unnamed
Year:
2022

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
other: • MatTek Corporation Protocol: In vitro EpiDermTM Skin Irritation Test (EPI-200-SIT) For use with MatTek Corporation’s Reconstructed Human Epidermal Model EpiDerm (EPI-200-SIT); Version 12/04/2020. • MatTek Corporation Protocol: EpiOcularTM Eye Irritation
Version / remarks:
Note:
The Pre-Test (Assessment of Colored or Staining Materials and Assessment of Direct Test Article Reduction by MTT) was performed according to the MatTek Protocol “EpiOcularTM Eye Irritation Test.
Reason:
The OECD TG 439 requires the evaluation of colored or staining materials spectrophotometrically but does not state the evaluation criteria. These criteria are missing in the MatTek protocol “In vitro EpiDermTM Skin Irritation Test”, too. But the identical scientific hypothesis is to clarify in the Eye Irritation Test and there the requirements are described.
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: UN GHS
Version / remarks:
published 2003, last (8th revision) 2019
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Version / remarks:
Reconstructed Human Epidermis Test Methods (14 June 2021), and as described in detail in the Protocol for:
In vitro EpiDermTM Skin Irritation Test (EPI-200-SIT) for use with MatTek Corporation’s Reconstructed Human Epidermal Model EpiDerm (EPI-200).
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Version / remarks:
06 July 2012
Deviations:
no
GLP compliance:
yes
Remarks:
Date of GLP Certificate: 2019-10-23

Test material

Constituent 1
Reference substance name:
Paraffin waxes (Fischer-Tropsch), isomerization
Cas Number:
2658498-20-3
Molecular formula:
C25H52 - C150H302
IUPAC Name:
Paraffin waxes (Fischer-Tropsch), isomerization
Details on test material:
- Purity: 100%
- Molecular weight: Not applicable (UVCB)
- Physical state / Appearance: Solid / white
- Expiry Date / Retest Date: Not indicated
- Storage Conditions: Room temperature
- Stability in Solvent: Not indicated
Specific details on test material used for the study:
Appearance: White, solid (waxy)
Storage Conditions: At room temperature
Stability in Solvent: Not indicated

In vitro test system

Test system:
human skin model
Source species:
other: Standard Assay Kit and MTT-100 kit were purchased from MatTek Corporation (82105 Bratislava, Slovakia, Lot No.: 36129).
Justification for test system used:
Dermal irritation is generally defined as "the production of reversible inflammatory changes in the skin". The potential for chemical induced skin irritation is an important consideration in establishing procedures for the safe handling, packing and transport of chemicals. It is usually determined in the in vivo Draize rabbit skin irritation test as described in OECD guideline 404. Because systemic reactions play a minor role in modulating local skin toxicity potential of chemicals, skin irritation potential may be predicted by in vitro systems, provided they are sufficiently complex to mimic human skin barrier and cell reactivity. In an international prevalidation study performed by ECVAM, the in vitro skin irritation test using the human skin model EpiDerm™ and EpiSkin™ and measurement of cell viability by dehydrogenase conversion of MTT into a blue formazan salt have turned out as a sufficiently promising predictor for skin irritancy potential.
Vehicle:
unchanged (no vehicle)
Details on test system:
In vitro Skin Irritation Test (OECD 439)
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit):25 +/- 2 mg (39.7 mg/cm2 according to guideline)

NEGATIVE CONTROL
- Concentration (if solution): 30 µL DPBS

POSITIVE CONTROL
- Concentration (if solution): 5% SDS solution in deionised water (MatTek)
Duration of treatment / exposure:
60 minutes
Number of replicates:
Three tissues

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Test Item
Value:
100.08
Vehicle controls validity:
not examined
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Remarks:
according to UN GHS and EU CLP regulations

Any other information on results incl. tables

Main Experiment: Results after treatment with test item and controls




























































































































































Treatment Group



Tissue No.



Well 1 OD 570 nm



Well 2 OD 570 nm



Well 3 OD 570 nm



Mean OD of
3 Wells



Mean OD


of 3 Wells blank


corrected



Mean


OD


of 3 tissues



Rel. Viability [%] Tissue
1, 2 + 3



Standard Deviation



Mean Rel. Viability


[%]



Treatment Group



Tissue No.



0.037



 



 



 



 



 



 



 



 



Blank



 



1.580



0.037



0.037



0.037



 



 



 



 



 



Negative Control



1



1.625



1.537



1.561



1.559



1.522



 



97.658



 



 



2



1.658



1.596



1.590



1.604



1.567



1.559



100.530



2.1



100.0



3



0.125



1.606



1.607



1.624



1.587



 



101.813



 



 



Positive Control



1



0.100



0.110



0.109



0.115



0.078



 



5.004



 



 



2



0.106



0.094



0.092



0.095



0.058



0.066



3.742



0.7



4.25



3



1.575



0.097



0.094



0.099



0.062



 



3.997



 



 



Test Item



1



1.626



1.567



1.565



1.569



1.532



 



98.297



 



 



2



1.607



1.609



1.611



1.615



1.579



1.560



101.272



1.6



100.08



3



 



 



 



1.606



1.569



 



100.669



 



 



OD: optical density

Applicant's summary and conclusion

Interpretation of results:
other: EU-GHS criteria not met
Conclusions:
In conclusion, it can be stated that in this study and under the experimental conditions reported, the registration substance is non-irritant to skin according to UN GHS and EU CLP regulation.
Executive summary:

This in vitro study was performed to assess the skin irritation potential of the registration substance 'Paraffin waxes (Fischer-Tropsch), isomerization' by means of the Human Skin Model Test.


The test item did not prove to be a MTT reducer in the MTT interference pre-experiment. Also, its intrinsic color was not intensive and the OD of the test item in deionised water or isopropanol at 570 nm after blank correction was < 0.08. Therefore, additional tests with freeze-killed tissues or viable tissues (without MTT addition) did not have to be performed.


Each three tissues of the human skin model EpiDerm were treated with the test item, the negative control (DPBS) or the positive control (5% SDS) for 60 minutes.


After treatment with the negative control the absorbance values were well within the required range of the acceptability criterion of mean OD 0.8 and ≤ 2.8 for the 60 minutes treatment interval, thus assuring the quality of the tissues.


Treatment with the positive control induced a decrease in the viability compared with the negative control to 4.25%, thus ensuring the validity of the test system.


The standard deviations between the three tissue percentage viability values of each group (test item, positive and negative controls) in the main test were below 18 (threshold according to OECD 439: ≤ 18), thus ensuring the validity of the study.


After treatment with the test item the mean viability value was 100.08% compared to the relative absorbance value of the negative control. This value is above the threshold for irritancy of ≤ 50%. Therefore, the test item is not considered to possess an irritant potential.